Fludarabine Phosphate Injection, Solution
Product Images NDC 25021-242

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Fludarabine Phosphate (NDC 25021-242). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Flu1n 0007 01)

Chemical structure of Fludarabine Phosphate, showing its molecular formula C10H13FN5O7P and molecular weight 365.2. The diagram displays the detailed atomic connectivity of the compound.*

FDA Label Image

Package Label – Principal Display Panel – Vial Label (Flu1n 0007 02)

Label for Fludarabine Phosphate Injection, USP by Sagent Pharmaceuticals, showing 50 mg per 2 mL (25 mg/mL) intravenous injection in a 2 mL single-dose vial. Includes caution as a cytotoxic agent, instructions for discarding unused portion, and manufacturer details from Sagent Pharmaceuticals, Schaumburg, IL, USA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.